The future of skin toxicology testing – Three-dimensional bioprinting meets microfluidics
Journal Title: International Journal of Bioprinting - Year 2019, Vol 5, Issue 2
Abstract
Over the years, the field of toxicology testing has evolved tremendously from the use of animal models to the adaptation of in vitro testing models. In this perspective article, we aim to bridge the gap between the regulatory authorities who performed the testing and approval of new chemicals and the scientists who designed and fabricated these in vitro testing models. An in-depth discussion of existing toxicology testing guidelines for skin tissue models (definition, testing models, principle, and limitations) is first presented to have a good understanding of the stringent requirements that are necessary during the testing process. Next, the ideal requirements of toxicology testing platform (in terms of fabrication, testing, and screening process) are then discussed. We envisioned that the integration of three-dimensional bioprinting within miniaturized microfluidics platform would bring about a paradigm shift in the field of toxicology testing; providing standardization in the fabrication process, accurate, and rapid deposition of test chemicals, real-time monitoring, and high throughput screening for more efficient skin toxicology testing.
Authors and Affiliations
Wei Long Ng, Wai Yee Yeong
Keywords
Related Articles
- EP ID EP678717
- DOI -
- Views 187
- Downloads 0
A novel 3D printing method for cell alignment and differentiation
The application of bioprinting allows precision deposition of biological materials for bioengineering applications. Here we propose a 2 stage methodology for bioprinting using a back pressure-driven, automated robotic di...
A multi-scale porous scaffold fabricated by a combined additive manufacturing and chemical etching process for bone tissue engineering
It is critical to develop a fabrication technology for precisely controlling an interconnected porous structure of scaffolds to mimic the native bone microenvironment. In this work, a novel combined process of additive m...
Novel ultrashort self-assembling peptide bioinks for 3D culture of muscle myoblast cells
The ability of skeletal muscle to self-repair after a traumatic injury, tumor ablation, or muscular disease is slow and limited, and the capacity of skeletal muscle to self-regenerate declines steeply with age. Tissue en...
Discovering new 3D bioprinting applications: Analyzing the case of optical tissue phantoms
Optical tissue phantoms enable to mimic the optical properties of biological tissues for biomedical device calibration, new equipment validation, and clinical training for the detection, and treatment of diseases. Unfort...
A perspective on 4D bioprinting
3D bioprinting has been invented for more than a decade. A disruptive progress is still lacking for the field to significantly move forward. Recently, the invention of 4D printing technology may point a way and hence the...